ABSTRACT
Objective:To investigate the clinical efficacy and safety of non-invasive bilevel positive airway pressure (BiPAP) ventilator combined with oxygen atomization in the treatment of chronic obstructive pulmonary disease (COPD) complicated with type Ⅱ respiratory failure.Methods:A total of 80 patients with COPD complicated with type Ⅱ respiratory failure admitted to Haiyan County People′s Hospital from June 2019 to July 2021 were selected, and they were divided into the observation group and the control group by the random number table method, with 40 cases in each group. Patients in both groups received conventional treatment, while patients in the control group were connected with BiPAP non-invasive ventilator and received non-invasive mechanical ventilation in S/T mode; the observation group was given aerosol inhalation drugs during ventilation, and both groups were treated for 7 d. Blood gas indicators and vital signs were collected before treatment and 7 d after treatment. Clinical symptoms were investigated by COPD patient Caring Assessment Tool (CAT) and Dyspnea Scale (DECAF). Serum levels of interleukin (IL)-10, tumor necrosis factor (TNF-α) and CD 4+/CD 8+ were determined, and treatment outcomes and adverse reactions were compared between the two groups. Results:After treatment, the partial pressure of oxygen (PaO 2) and the oxygen saturation (SaO 2) in the observation group were higher than those in the control group: (73.41 ± 5.26) mmHg(1 mmHg = 0.133 kPa) vs. (65.11 ± 4.33) mmHg, 0.921 ± 0.052 vs. 0.884 ± 0.039; the arterial partial pressure of carbon dioxide (PaCO 2), heart rate (HR), respiratory rate (RR) were lower than those in the control group: (45.20 ± 5.33) mmHg vs. (50.52 ± 5.96) mmHg, (90.12 ± 8.56) times/min vs. (98.52 ± 9.63) times/min, (17.41 ± 2.26) times/min vs. (22.10 ± 3.05) times/min, there were statistical differences ( P<0.05). After treatment, CAT scores and DECAF scores in the observation group were lower than those in the control group: (8.45 ± 1.63) scores vs. (12.77 ± 2.36) scores, (0.89 ± 0.15) scores vs. (1.15 ± 0.19) scores, there were statistical differences ( P<0.05). After treatment, the levels of IL-10 and CD 4+/CD 8+ in the observation group were higher than those in the control group: (15.28 ± 3.12) ng/L vs. (13.41 ± 2.96) ng/L, 1.71 ± 0.38 vs. 1.54 ± 0.30; while the level of TNF-α was lower than that in the control group: (215.27 ± 33.96) ng/L vs. (251.11 ± 50.95) ng/L, there were statistical differences ( P<0.05). The hospitalization time in the observation group was shorter than that in the control group: (13.52 ± 3.96) d vs. (15.22 ± 2.74) d, there was statistical difference ( P<0.05). The rates of tracheal intubation and the incidence of adverse reactions between the two groups had no significant differences ( P>0.05). Conclusions:Non-invasive BiPAP ventilator combined with oxygen atomization can improve blood gas index, vital signs and clinical symptoms of COPD patients complicated with type Ⅱ respiratory failure and reduce inflammatory response.
ABSTRACT
Objective:To explore the diagnostic value of the combined detection of galactomannan (Gm) in bronchoalveolar lavage fluid (BALF) and IgG of aspergillus fumigatus in blood for pulmonary aspergillosis.Methods:Seventy-four patients with pulmonary aspergillosis admitted to Haiyan People′s Hospital from February 2017 to September 2019 were divided into chronic pulmonary aspergillosis group (35 cases) and invasive pulmonary aspergillosis group (39 cases). The BALF of ttwo groups were collected, the Gm level of BALF was tested, and the IgG level of blood aspergillus fumigatus was detected by using the aspergillus IgG enzyme-linked immunosorbent assay (ELISA) kit, and the positive prediction rate, negative prediction rate, diagnostic sensitivity, specificity and accuracy of the two methods was compared.Results:The Gm I value of BALF and the IgG level of blood in invasive pulmonary aspergillosis group were lower than those in chronic pulmonary aspergillosis group: 0.65 ± 0.09 vs. 0.98 ± 0.12, (118.95 ± 12.31) kAU/L vs. (147.63 ± 15.32) kAU/L, and there were significant differences ( P<0.05). The positive predictive rate and negative predictive rate in combined detection of detection of GMI and IgG in BALF and blood were significantly higher than those in the single detection of GMI and IgG in BLAF and blood: 92.50%(37/40) vs. 61.90%(26/42) and 61.54%(24/39), 88.24%(30/34) vs. 53.13%(17/32) and 51.43%(18/35), and there were significant differences ( P<0.05). There was a certain correlation between the severity of pulmonary aspergillosis and the Gm I value of BALF and the IgG level of blood aspergillus fumigatus. The sensitivity and accuracy of the diagnosis in combined detection of Gm I and IgG in BALF and blood were higher than those in the single detection of Gm I and IgG in BALF and blood: 92.86%(39/42) vs. 65.00%(26/40) and 67.57%(25/37), 83.78%(62/74) vs. 75.68%(56/74) and 75.68%(56/74), the diagnostic specificity was lower than that of the single detection of GM I and IgG in BALF and blood: 71.88%(23/32) vs. 88.24%(30/34) and 83.78%(31/37), and there were significant differences ( P<0.05). Conclusions:There is a certain correlation between Gm in BALF and aspergillus fumigatus IgG in blood and the symptoms of pulmonary aspergillosis. The combined detection of Gm in BALF and aspergillus fumigatus IgG in blood is of great significance for the clinical diagnosis and treatment of pulmonary aspergillosis.